Japan's Soft­Bank plots bil­lions in biotech in­vest­ments in move that could keep the val­u­a­tion flood ris­ing — re­port

The val­u­a­tion crazy train in biotech con­tin­ues to roll in­to the new year with more than a dozen com­pa­nies tak­ing a chance on Nas­daq and mon­ey flow­ing in from all sides. Now, a Japan­ese in­sti­tu­tion­al in­vestor is re­port­ed­ly weigh­ing an en­try in­to the mar­ket in a big way — will it keep the bit­coin-es­que flood ris­ing?

Al­ready a part-time in­vestor in biotech, Soft­Bank could drop bil­lions of dol­lars in­to the in­dus­try as part of helms­man Masayoshi Son’s plan to spend around $80 bil­lion of the firm’s own as­sets, ac­cord­ing to a re­port from Bloomberg cit­ing peo­ple fa­mil­iar with the plan.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER